donepezil has been researched along with neostigmine in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.88) | 18.2507 |
| 2000's | 1 (5.88) | 29.6817 |
| 2010's | 15 (88.24) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Karpińska, MM; Matysiak, J; Niewiadomy, A; Skrzypek, A | 1 |
| Arif, M; Iqbal, J; Mahmood, S; Muddassar, M; Raza, A; Raza, R; Saeed, A | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Iqbal, J; Khan, MS; Mahesar, PA; Matin, A; Saeed, A; Shahid, M; Zaib, S | 1 |
| Ibrar, A; Iqbal, J; Khan, I; Rama, NH; Simpson, J; Zaib, S | 1 |
| Ahmad, S; Bajorath, J; Furtmann, N; Hameed, S; Ibrar, A; Iqbal, J; Khan, I; Simpson, J; Zaib, S | 1 |
| Alharthy, RD; Bajorath, J; Furtmann, N; Hameed, A; Iqbal, J; Khan, KM; Shah, SJ; Tahir, MN; Zehra, ST | 1 |
| Ashraf, S; Iftikhar, J; Iqbal, J; Muddassar, M; Saeed, A; Zaib, S; Zhang, KY | 1 |
| Abbas, S; Al-Rashida, M; Ayub, K; Bajorath, J; Hameed, A; Iqbal, J; Khan, KM; Mahmood, T; Nisa, RU; Zehra, ST | 1 |
| Ji, J; Peng, Y; Rakesh, KP; Wang, S; Xu, M; Zhu, L | 1 |
| Castellani, WJ; Sprung, J; Srinivasan, V; Udayashankar, S | 1 |
| Kaur, J; Zhang, MQ | 1 |
| Hu, XJ; Kehr, J; Ogren, SO; Osborne, P; Stenfors, C; Wang, FH; Yoshitake, T | 1 |
| Ishii, K; Kubota, Y; Nakahara, T; Sakamoto, K; Shimizu, N | 1 |
| Nakatsuka, H; Sato, T | 1 |
| Farooq Rizvi, SU; Iqbal, J; Najam-Ul-Haq, M; Shah, HS; Shah, MS | 1 |
2 review(s) available for donepezil and neostigmine
| Article | Year |
|---|---|
Triazole derivatives as inhibitors of Alzheimer's disease: Current developments and structure-activity relationships.
Topics: Acetylcholinesterase; Alzheimer Disease; Butyrylcholinesterase; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Humans; Molecular Structure; Neuroprotective Agents; Structure-Activity Relationship; Triazoles | 2019 |
Molecular modelling and QSAR of reversible acetylcholines-terase inhibitors.
Topics: Alkaloids; Alzheimer Disease; Cholinesterase Inhibitors; Crystallography, X-Ray; Donepezil; Drug Design; Glaucoma; Humans; Indans; Models, Molecular; Myasthenia Gravis; Neostigmine; Physostigmine; Piperidines; Sesquiterpenes; Structure-Activity Relationship; Surface Properties; Tacrine | 2000 |
15 other study(ies) available for donepezil and neostigmine
| Article | Year |
|---|---|
Synthesis and anticholinesterase activities of novel 1,3,4-thiadiazole based compounds.
Topics: Butyrylcholinesterase; Cholinesterase Inhibitors; Cholinesterases; Dose-Response Relationship, Drug; Molecular Structure; Structure-Activity Relationship; Thiadiazoles | 2013 |
Synthesis and biological evaluation of 3-thiazolocoumarinyl Schiff-base derivatives as cholinesterase inhibitors.
Topics: Acetylcholinesterase; Animals; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Coumarins; Electrophorus; Horses; Molecular Docking Simulation; Schiff Bases; Thiazoles | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Synthesis, cytotoxicity and molecular modelling studies of new phenylcinnamide derivatives as potent inhibitors of cholinesterases.
Topics: Acetylcholinesterase; Amides; Antineoplastic Agents; Butyrylcholinesterase; Cell Proliferation; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Tumor Cells, Cultured | 2014 |
Synthesis, crystal structure and biological evaluation of some novel 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazoles and 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazines.
Topics: Acetylcholinesterase; Antineoplastic Agents; Antiprotozoal Agents; Butyrylcholinesterase; Cell Line; Cell Proliferation; Cholinesterase Inhibitors; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Fibroblasts; Humans; Leishmania major; Models, Molecular; Molecular Structure; Parasitic Sensitivity Tests; Structure-Activity Relationship; Thiadiazines; Thiadiazoles | 2014 |
Active compounds from a diverse library of triazolothiadiazole and triazolothiadiazine scaffolds: synthesis, crystal structure determination, cytotoxicity, cholinesterase inhibitory activity, and binding mode analysis.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Butyrylcholinesterase; Cell Line, Tumor; Chlorocebus aethiops; Cholinesterase Inhibitors; Crystallography, X-Ray; Electrophorus; Horses; Humans; Models, Molecular; Structure-Activity Relationship; Thiadiazines; Thiadiazoles; Vero Cells | 2014 |
Syntheses, cholinesterases inhibition, and molecular docking studies of pyrido[2,3-b]pyrazine derivatives.
Topics: Acetylcholinesterase; Alzheimer Disease; Butyrylcholinesterase; Cholinesterase Inhibitors; Drug Design; Humans; Molecular Docking Simulation; Pyrazines; Structure-Activity Relationship | 2015 |
Synthesis, cholinesterase inhibition and molecular modelling studies of coumarin linked thiourea derivatives.
Topics: Acetylcholinesterase; Butyrylcholinesterase; Cholinesterase Inhibitors; Coumarins; Dose-Response Relationship, Drug; Humans; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Thiourea | 2015 |
One-pot synthesis of tetrazole-1,2,5,6-tetrahydronicotinonitriles and cholinesterase inhibition: Probing the plausible reaction mechanism via computational studies.
Topics: Acetylcholinesterase; Alzheimer Disease; Butyrylcholinesterase; Cholinergic Agents; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Humans; Molecular Structure; Nitriles; Quantum Theory; Structure-Activity Relationship | 2016 |
The effects of donepezil and neostigmine in a patient with unusual pseudocholinesterase activity.
Topics: Aged; Aged, 80 and over; Anesthesia; Butyrylcholinesterase; Cholinesterase Inhibitors; Donepezil; Drug Interactions; Female; Humans; Indans; Neostigmine; Neuromuscular Blockade; Neuromuscular Blocking Agents; Nootropic Agents; Piperidines | 1998 |
The selective 5-HT(1A) receptor antagonist NAD-299 increases acetylcholine release but not extracellular glutamate levels in the frontal cortex and hippocampus of awake rat.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Acetylcholine; Animals; Area Under Curve; Benzopyrans; Cholinesterase Inhibitors; Donepezil; Dose-Response Relationship, Drug; Extracellular Fluid; Frontal Lobe; Glutamic Acid; Hippocampus; Indans; Male; Microdialysis; Neostigmine; Piperidines; Rats; Rats, Sprague-Dawley; Serotonin Antagonists; Serotonin Receptor Agonists; Wakefulness | 2010 |
Contribution of cyclooxygenase-dependent mechanisms to contractile responses to donepezil in the rat urinary bladder.
Topics: Animals; Atropine; Cholinesterase Inhibitors; Donepezil; Indans; Indomethacin; Male; Muscle Contraction; Neostigmine; Piperidines; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Sprague-Dawley; Urinary Bladder | 2010 |
[Anticholinesterases; peripheral and central effects].
Topics: Alzheimer Disease; Brain; Cholinesterase Inhibitors; Donepezil; Humans; Indans; Neostigmine; Neuromuscular Blocking Agents; Neuromuscular Junction; Piperidines | 2013 |
Quinoline containing chalcone derivatives as cholinesterase inhibitors and their in silico modeling studies.
Topics: Acetylcholinesterase; Butyrylcholinesterase; Chalcones; Cholinesterase Inhibitors; Donepezil; Enzyme Assays; Humans; Indans; Kinetics; Ligands; Molecular Docking Simulation; Neostigmine; Piperidines; Protein Binding; Quinolines; Structure-Activity Relationship | 2018 |